Global Monoclonal Antibodies Market Size & Outlook
Global monoclonal antibodies market, 2018-2030 (US$B)
Related Markets
Global monoclonal antibodies market highlights
- The global monoclonal antibodies market generated a revenue of USD 210,059.1 billion in 2022 and is expected to reach USD 494,531.7 billion by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 11% by 2030.
- In terms of segment, human accounted for a revenue of USD 129,006.3 billion in 2022.
- Humanized is the most lucrative source type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 210,059.1 billion |
| Market revenue in 2030 | USD 494,531.7 billion |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Human |
| Fastest growing segment | Humanized |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD billion |
| Market segmentation | Human, Humanized, Chimeric, Murine |
Other key industry trends
- In terms of revenue, the North America accounted for 46.1% of the global monoclonal antibodies market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 19,764.4 billion by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Monoclonal Antibodies Market Scope
Monoclonal Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Daiichi Sankyo Company, Ltd. (American Regent. Inc.) | View profile | - | - | - |
| Eli Lilly and Company | View profile | - | - | - |
| GlaxoSmithKline PLC | View profile | - | - | - |
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Bristol Myers Squibb | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
Global monoclonal antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to monoclonal antibodies market will help companies and investors design strategic landscapes.
Human was the largest segment with a revenue share of 61.41% in 2022. Horizon Databook has segmented the Global monoclonal antibodies market based on human, humanized, chimeric, murine covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Monoclonal Antibodies Source Type Outlook (Revenue, USD Billion, 2018-2030)
- Human
- Humanized
- Chimeric
- Murine
- Global Monoclonal Antibodies Production Type Outlook (Revenue, USD Billion, 2018-2030)
- In vitro
- In vivo
- Global Monoclonal Antibodies Application Outlook (Revenue, USD Billion, 2018-2030)
- Oncology
- Autoimmune diseases
- Infectious diseases
- Neurological Diseases
- Others
- Global Monoclonal Antibodies End Use Outlook (Revenue, USD Billion, 2018-2030)
- Hospitals
- Speciality Centers
- Others
Reasons to subscribe to Global monoclonal antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global monoclonal antibodies market databook
-
Our clientele includes a mix of monoclonal antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global monoclonal antibodies market , including forecasts for subscribers. This global databook contains high-level insights into Global monoclonal antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global monoclonal antibodies market size, by regions, 2018-2030 (US$B)
Top 10 countries: Monoclonal antibodies market size, 2022 (US$B)
Global monoclonal antibodies market share, by source type, 2022 & 2030 (%, US$B)
Monoclonal antibodies market: Opportunity assessment by country
Global monoclonal antibodies market, by region, 2022 (US$B)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
